Literature DB >> 25451946

Atypical/malignant urothelial cells in routine urinary sediment: worth knowing and reporting.

G B Fogazzi1, F Pallotti2, G Garigali3.   

Abstract

BACKGROUND: Urinary cytology (Ucytol), which is performed in pathology laboratories on fixed and stained samples, represents the gold standard for the identification of atypical/malignant urothelial cells (A/MUC) due to urothelial carcinoma. In this paper we describe three patients in whom A/MUC, due to a bladder carcinoma, were identified with conventional urine sediment (Used) examination on unfixed and unstained samples.
METHODS: Included are urine samples prepared with conventional and standardized techniques as currently used in general clinical laboratories. Samples were examined with phase contrast microscopy. A/MUC were identified according to the criteria currently used for Ucytol.
RESULTS: A/MUC (i.e., cells with unusual and pleomorphic size and shape, increased nuclear/cytoplasmic ratio, increased number of nuclei, irregular nuclear borders and irregular chromatin patterns, either isolated or in clusters) were identified in the urine of three patients, all of whom were found to have bladder carcinoma by cystoscopy.
CONCLUSIONS: At variance with the common and widespread view, A/MUC can also be identified with conventional Used examination, even though Ucytol still represents the gold standard method.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical/malignant urothelial cells; Bladder carcinoma; Phase contrast microscopy; Urinary sediment

Mesh:

Year:  2014        PMID: 25451946     DOI: 10.1016/j.cca.2014.10.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Investigation of Atyp.C using UF-5000 flow cytometer in patients with a suspected diagnosis of urothelial carcinoma: a single-center study.

Authors:  Chunyun Ren; Xing Wang; Chunwei Yang; Shengchao Li; Shuangchun Liu; Hongcui Cao
Journal:  Diagn Pathol       Date:  2020-06-25       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.